| Dr Michael D Jackson, MD | |
|
311 E Spruce St, Garden City, KS 67846-5679 | |
| (620) 275-3700 | |
| Not Available |
| Full Name | Dr Michael D Jackson |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 311 E Spruce St, Garden City, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255383741 | NPI | - | NPPES |
| 100208190C | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 04-19573 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael D Jackson, MD 311 E Spruce St, Garden City, KS 67846-5679 Ph: (620) 275-3700 | Dr Michael D Jackson, MD 311 E Spruce St, Garden City, KS 67846-5679 Ph: (620) 275-3700 |
News Archive
Machine learning, also known as artificial intelligence, could be a useful tool for predicting how well people at high risk of psychosis or with recent onset depression will function socially in the future, an international research study has found.
Data presented today at the American Society of Hypertension, Inc.'s 25th Annual Scientific Meeting and Exposition demonstrate a link between short cycles of sleep, stroke and silent cerebral infarct, or "silent strokes," in elderly hypertensive patients.
As the 193 WHO member states gather at next week's World Health Assembly (WHA) "a draft global code of practice on the international recruitment of health personnel will be on the agenda. Negotiation and adoption of a WHO code of practice is an unprecedented opportunity to advance global consensus to address the critical challenges of migration of health workers and its effect on health systems worldwide," the authors of a Lancet Comment write.
Lannett Company, Inc. today announced the U.S. Food and Drug Administration (FDA) approved its Abbreviated New Drug Application (ANDA) for Phentermine Resin Extended-Release Capsules, 15 mg and 30 mg, representing the fourth product approval the company has received in the last five weeks.
Human Genome Sciences, Inc. today announced the presentation of additional results from BLISS-76, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Vancouver at the 9th International Congress on Systemic Lupus Erythematosus on Friday and Saturday, June 25-26.
› Verified 4 days ago
John Christian Birky, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 311 E Spruce St, Ste 2b, Garden City, KS 67846 Phone: 620-765-4324 Fax: 620-464-4732 | |
Sarah Cokenakes, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 310 E Walnut St, Garden City, KS 67846 Phone: 620-275-9752 Fax: 620-275-4306 | |
Dr. Pamela E Stewart, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 712 Saint John St, Garden City, KS 67846 Phone: 620-275-1766 | |
Dr. Eric R Oppliger, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 311 E Spruce St, Garden City, KS 67846 Phone: 620-275-3703 Fax: 620-275-3717 | |
Dr. Harold L Perkins, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 E Spruce St, Garden City, KS 67846 Phone: 620-272-2201 | |
Bradley Keith Stucky, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 911 N Main St, Garden City, KS 67846 Phone: 620-276-8201 Fax: 620-276-8739 |